Speakers

Dr. Navratil has served as our chief development officer since April 2022. He previously served as our senior vice president, research and development since joining…

Abla Creasey is the Vice President of Therapeutics Development. In this capacity, she leads all programs in Translational and Clinical development, with a focus on…

Retinal specialist with both extensive basic science training, clinical trial experience and drug development experience in Big Pharma. Main research interest is macular diseases, including…

Dr. Sherif joined Oculis as CEO in 2017 from Novartis where he served as Entrepreneur in Residence at the Novartis Venture Fund and since 2022,…

Hannah H. Chang is a Managing Director at Platanus, a global evergreen investment fund. Dr. Chang leads the firm’s healthcare venture capital strategy, investing in…

Mark L. Baum is the founder, Chairman of the Board, and CEO of Harrow. For the 2014-2017 periods, Harrow (formerly Imprimis Pharmaceuticals) was named by…

Dr. Frank W. Bowden, III, is the founder of Bowden Eye & Associates, a successful integrated eye care practice which he established in Jacksonville, Florida…

Jonathan Liu is Senior Director of Business Development at Topcon Healthcare responsible for corporate venture capital investments. He previously served as Global Director of Product…

Since 2019, Josh Chiwata has been the Director of Venture Management and Global Business Development at Santen, Inc. Prior to this role, he served as…

Doug is an entrepreneurial life scientist-PhD immunologist with more than twenty years of professional experience spanning both major pharmaceutical and academic environments. His collective expertise…

Murielle joined Intuitive Ventures in 2023. She is a senior investor and brings a depth of experience across digital health, diagnostics, and biotech domains to…